Immuron will launch ProIBS® for the treatment of symptoms related to IBS in the retail pharmacy sales channel. Immuron has been a leader in digestive health in Australia for many years.
Immuron Limited has announced an exclusive distribution agreement to launch ProIBS® in Australia and New Zealand, targeting symptoms of irritable bowel syndrome (IBS) through retail pharmacies.
Immuron will launch ProIBS for the treatment of symptoms related to IBS in the retail pharmacy sales channel. Immuron has been a leader in digestive health in Australia for many years. ProIBS will ...